| Id |
Subject |
Object |
Predicate |
Lexical cue |
| 17541304-0#0#4#gene2146 |
0-4 |
gene2146 |
denotes |
EZH2 |
| 17541304-0#86#92#gene317 |
86-92 |
gene317 |
denotes |
APAF-1 |
| 17541304-0#113#155#diseaseC0279680 |
113-155 |
diseaseC0279680 |
denotes |
transitional cell carcinoma of the bladder |
| 17541304-3#65#69#gene2146 |
445-449 |
gene2146 |
denotes |
EZH2 |
| 17541304-3#104#110#gene317 |
484-490 |
gene317 |
denotes |
APAF-1 |
| 17541304-3#112#118#gene1612 |
492-498 |
gene1612 |
denotes |
DAPK-1 |
| 17541304-3#123#130#gene3486 |
503-510 |
gene3486 |
denotes |
IGFBP-3 |
| 17541304-3#157#184#diseaseC0007138 |
537-564 |
diseaseC0007138 |
denotes |
transitional cell carcinoma |
| 17541304-3#186#189#diseaseC1861305 |
566-569 |
diseaseC1861305 |
denotes |
TCC |
| 17541304-8#146#152#gene317 |
1329-1335 |
gene317 |
denotes |
APAF-1 |
| 17541304-8#216#219#diseaseC1861305 |
1399-1402 |
diseaseC1861305 |
denotes |
TCC |
| 17541304-9#27#30#diseaseC1861305 |
1431-1434 |
diseaseC1861305 |
denotes |
TCC |
| 17541304-9#163#167#gene2146 |
1567-1571 |
gene2146 |
denotes |
EZH2 |
| 17541304-9#187#193#gene1612 |
1591-1597 |
gene1612 |
denotes |
DAPK-1 |
| 17541304-10#34#38#gene2146 |
1689-1693 |
gene2146 |
denotes |
EZH2 |
| 17541304-10#54#60#gene317 |
1709-1715 |
gene317 |
denotes |
APAF-1 |
| 17541304-10#88#105#diseaseC0178874 |
1743-1760 |
diseaseC0178874 |
denotes |
tumor progression |
| 0#4#gene2146113#155#diseaseC0279680 |
17541304-0#0#4#gene2146 |
17541304-0#113#155#diseaseC0279680 |
associated_with |
EZH2,transitional cell carcinoma of the bladder |
| 104#110#gene317157#184#diseaseC0007138 |
17541304-3#104#110#gene317 |
17541304-3#157#184#diseaseC0007138 |
associated_with |
APAF-1,transitional cell carcinoma |
| 104#110#gene317186#189#diseaseC1861305 |
17541304-3#104#110#gene317 |
17541304-3#186#189#diseaseC1861305 |
associated_with |
APAF-1,TCC |
| 112#118#gene1612157#184#diseaseC0007138 |
17541304-3#112#118#gene1612 |
17541304-3#157#184#diseaseC0007138 |
associated_with |
DAPK-1,transitional cell carcinoma |
| 112#118#gene1612186#189#diseaseC1861305 |
17541304-3#112#118#gene1612 |
17541304-3#186#189#diseaseC1861305 |
associated_with |
DAPK-1,TCC |
| 123#130#gene3486157#184#diseaseC0007138 |
17541304-3#123#130#gene3486 |
17541304-3#157#184#diseaseC0007138 |
associated_with |
IGFBP-3,transitional cell carcinoma |
| 123#130#gene3486186#189#diseaseC1861305 |
17541304-3#123#130#gene3486 |
17541304-3#186#189#diseaseC1861305 |
associated_with |
IGFBP-3,TCC |
| 146#152#gene317216#219#diseaseC1861305 |
17541304-8#146#152#gene317 |
17541304-8#216#219#diseaseC1861305 |
associated_with |
APAF-1,TCC |
| 163#167#gene214627#30#diseaseC1861305 |
17541304-9#163#167#gene2146 |
17541304-9#27#30#diseaseC1861305 |
associated_with |
EZH2,TCC |
| 187#193#gene161227#30#diseaseC1861305 |
17541304-9#187#193#gene1612 |
17541304-9#27#30#diseaseC1861305 |
associated_with |
DAPK-1,TCC |
| 34#38#gene214688#105#diseaseC0178874 |
17541304-10#34#38#gene2146 |
17541304-10#88#105#diseaseC0178874 |
associated_with |
EZH2,tumor progression |
| 54#60#gene31788#105#diseaseC0178874 |
17541304-10#54#60#gene317 |
17541304-10#88#105#diseaseC0178874 |
associated_with |
APAF-1,tumor progression |
| 65#69#gene2146157#184#diseaseC0007138 |
17541304-3#65#69#gene2146 |
17541304-3#157#184#diseaseC0007138 |
associated_with |
EZH2,transitional cell carcinoma |
| 65#69#gene2146186#189#diseaseC1861305 |
17541304-3#65#69#gene2146 |
17541304-3#186#189#diseaseC1861305 |
associated_with |
EZH2,TCC |
| 86#92#gene317113#155#diseaseC0279680 |
17541304-0#86#92#gene317 |
17541304-0#113#155#diseaseC0279680 |
associated_with |
APAF-1,transitional cell carcinoma of the bladder |
